Each ml of SP Sustanon contains active substances: 60 mg / ml testosterone propionate – 120 mg testosterone phenylpropionate – 120 mg testosterone Isocaproat – 200 mg testosterone decanoate – 500 mg
For intramuscular use only;
In men Sustanon is administrated to treat androgenic deficit after castration, eunuchoidism, hypopituitarism, provenance hormonal impotence, male climax symptoms (decreased libido and physical and intellectual activity), some forms of infertility with impaired spermatogenesis, osteoporosis caused by androgen insufficiency. In women, Sustanon is used to treat high levels of estrogen, uterine myoma; endometriosis; breast cancer; osteoporosis.
Sustanon is not indicated to be used in individual hypersensitivity to the drug, prostate and breast carcinoma; prostate hyperplasia along with disorder symptoms of urination; nephrosis or the nephrotic phase of nephritis, edema; hypercalcemia; disturbances of liver function; diabetes; heart failure or coronary, myocardial infarction, atherosclerosis in elderly men; pregnancy, lactation.
Sustanon is administered by deep intramuscular injection. The dosage is determined individually depending on the indication and the patient’s responsiveness.
Typically, to adults is administered intramuscularly 1 ml once in 14 days; when a therapeutic effect is achieved, Sustanon is administered 1 ml intramuscular once in 28 days. The length of the treatment is determined individually.
In male sterility (azoospermia, oligospermia) 2 ml 1 time in 2 weeks (at the appearance of painful erection the treatment is discontinued).
In breast cancer in women: 1-2 ml every 1-2 weeks during the treatment period.
The drug is not administered intravenously!